CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹1,213 Cr | ₹864 Cr | ₹689 Cr | ₹383 Cr | ₹571 Cr |
What is the latest Capital Work in Progress ratio of CIPLA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹1,213 Cr |
| Mar2024 | ₹864 Cr |
| Mar2023 | ₹689 Cr |
| Mar2022 | ₹383 Cr |
| Mar2021 | ₹571 Cr |
How is Capital Work in Progress of CIPLA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,213 Cr | 40.31 | |
| Mar2024 | ₹864 Cr | 25.41 | |
| Mar2023 | ₹689 Cr | 79.99 | |
| Mar2022 | ₹383 Cr | -32.92 | |
| Mar2021 | ₹571 Cr | - | |
Compare Capital Work in Progress of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹108,705.6 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| MANKIND PHARMA | ₹88,961.6 Cr | 5.8% | 1.9% | -13.1% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.3% |
1.3% |
-9.4% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses